BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 7692148)

  • 1. Hypertension as a risk factor for cardiac events--epidemiologic results of long-term studies.
    Kannel WB
    J Cardiovasc Pharmacol; 1993; 21 Suppl 2():S27-37. PubMed ID: 7692148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potency of vascular risk factors as the basis for antihypertensive therapy.
    Kannel WB
    Eur Heart J; 1992 Dec; 13 Suppl G():34-42. PubMed ID: 1486903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertension. Relationship with other risk factors.
    Kannel WB
    Drugs; 1986; 31 Suppl 1():1-11. PubMed ID: 3720567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertension, hypertrophy, and the occurrence of cardiovascular disease.
    Kannel WB
    Am J Med Sci; 1991 Oct; 302(4):199-204. PubMed ID: 1833977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of a new electrocardiographic method for diagnosis of left ventricular hypertrophy in essential hypertension.
    Verdecchia P; Schillaci G; Borgioni C; Ciucci A; Gattobigio R; Zampi I; Porcellati C
    J Am Coll Cardiol; 1998 Feb; 31(2):383-90. PubMed ID: 9462583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of multiple risk factors on the hazard of hypertension.
    Kannel WB
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S53-7. PubMed ID: 11527137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertension and other risk factors in coronary heart disease.
    Kannel WB
    Am Heart J; 1987 Oct; 114(4 Pt 2):918-25. PubMed ID: 3661384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of antihypertensive drug treatment on the incidence of cardiovascular morbidity and mortality in mild arterial hypertension].
    Tomov I
    Vutr Boles; 1985; 24(6):39-47. PubMed ID: 3913145
    [No Abstract]   [Full Text] [Related]  

  • 9. Epidemiological evaluation of known and suspected cardiovascular risk factors in chronic renal impairment.
    Landray MJ; Thambyrajah J; McGlynn FJ; Jones HJ; Baigent C; Kendall MJ; Townend JN; Wheeler DC
    Am J Kidney Dis; 2001 Sep; 38(3):537-46. PubMed ID: 11532686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiologic appraisal of hypertension as a coronary risk factor in the elderly.
    O'Donnell CJ; Kannel WB
    Am J Geriatr Cardiol; 2002; 11(2):86-92. PubMed ID: 11872966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk stratification in hypertension: new insights from the Framingham Study.
    Kannel WB
    Am J Hypertens; 2000 Jan; 13(1 Pt 2):3S-10S. PubMed ID: 10678282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An integrated view of hypertension.
    Kannel WB
    J Hum Hypertens; 1989 Dec; 3 Suppl 2():3-8. PubMed ID: 2607526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Associations between arterial hypertension and other cardiovascular risk factors in subjects over 65 years of age].
    Fiandra U; Bo M; Fonte G; Casoli G; Ferrario E
    Recenti Prog Med; 1995 Apr; 86(4):147-54. PubMed ID: 7617957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood pressure control.
    Black HR
    Am J Med; 1996 Oct; 101(4A):4A50S-55S. PubMed ID: 8900337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation of electrocardiographic left ventricular hypertrophy to blood pressure, body mass index, serum lipids and blood sugar levels in adult Nigerians.
    Opadijo OG; Omotoso AB; Akande AA
    Afr J Med Med Sci; 2003 Dec; 32(4):395-9. PubMed ID: 15259925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk predictors, risk indicators, and benefit factors in hypertension.
    Dollery CT
    Am J Med; 1987 Jan; 82(1A):2-8. PubMed ID: 3799698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardioprotection and antihypertensive therapy: the key importance of addressing the associated coronary risk factors (the Framingham experience).
    Kannel WB
    Am J Cardiol; 1996 Feb; 77(6):6B-11B. PubMed ID: 8848993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hazards, risks, and threats of heart disease from the early stages to symptomatic coronary heart disease and cardiac failure.
    Kannel WB
    Cardiovasc Drugs Ther; 1997 May; 11 Suppl 1():199-212. PubMed ID: 9211012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of coronary and cerebrovascular morbidity and mortality by direct continuous ambulatory blood pressure monitoring in essential hypertension.
    Khattar RS; Swales JD; Banfield A; Dore C; Senior R; Lahiri A
    Circulation; 1999 Sep; 100(10):1071-6. PubMed ID: 10477532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Framingham Study: ITS 50-year legacy and future promise.
    Kannel WB
    J Atheroscler Thromb; 2000; 6(2):60-6. PubMed ID: 10872616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.